Menu
GeneBe

ATAD3A

ATPase family AAA domain containing 3A, the group of AAA ATPases

Basic information

Region (hg38): 1:1512161-1534685

Links

ENSG00000197785NCBI:55210OMIM:612316HGNC:25567Uniprot:Q9NVI7AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

  • pontocerebellar hypoplasia, hypotonia, and respiratory insufficiency syndrome, neonatal lethal (Strong), mode of inheritance: AR
  • Harel-Yoon syndrome (Definitive), mode of inheritance: Semidominant
  • Harel-Yoon syndrome (Moderate), mode of inheritance: AD
  • pontocerebellar hypoplasia, hypotonia, and respiratory insufficiency syndrome, neonatal lethal (Moderate), mode of inheritance: AR
  • Harel-Yoon syndrome (Strong), mode of inheritance: AD
  • Harel-Yoon syndrome (Strong), mode of inheritance: AR

Clinical Genomic Database

Source: CGD

ConditionInheritanceIntervention CategoriesIntervention/Rationale Manifestation CategoriesReferences
Harel-Yoon syndrome; Pontocerebellar hypoplasia, hypotonia, and respiratory insufficiency syndrome, neonatal lethalAD/ARGeneralGenetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testingBiochemical; Cardiovascular; Craniofacial; Musculoskeletal; Ophthalmologic; Neurologic; Pulmonary27640307; 28549128; 29053797

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the ATAD3A gene.

  • not provided (130 variants)
  • Inborn genetic diseases (59 variants)
  • Harel-Yoon syndrome (50 variants)
  • Pontocerebellar hypoplasia, hypotonia, and respiratory insufficiency syndrome, neonatal lethal (14 variants)
  • not specified (12 variants)
  • Harel-Yoon syndrome;Pontocerebellar hypoplasia, hypotonia, and respiratory insufficiency syndrome, neonatal lethal (11 variants)
  • Pontocerebellar hypoplasia, hypotonia, and respiratory insufficiency syndrome, neonatal lethal;Harel-Yoon syndrome (2 variants)
  • Congenital cerebellar hypoplasia (1 variants)
  • - (1 variants)

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the ATAD3A gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
1
clinvar
30
clinvar
5
clinvar
36
missense
1
clinvar
3
clinvar
119
clinvar
8
clinvar
5
clinvar
136
nonsense
2
clinvar
3
clinvar
2
clinvar
7
start loss
1
clinvar
1
frameshift
3
clinvar
1
clinvar
4
inframe indel
4
clinvar
1
clinvar
5
splice donor/acceptor (+/-2bp)
5
clinvar
1
clinvar
6
splice region
8
6
2
16
non coding
9
clinvar
2
clinvar
11
clinvar
22
Total 3 15 137 41 21

Highest pathogenic variant AF is 0.0000197

Variants in ATAD3A

This is a list of pathogenic ClinVar variants found in the ATAD3A region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
1-1512268-C-T Uncertain significance (Nov 15, 2022)2502134
1-1512270-T-A Likely pathogenic (Sep 12, 2023)1710696
1-1512287-A-C Uncertain significance (Mar 31, 2022)1707751
1-1512287-A-G Harel-Yoon syndrome Benign (Jan 01, 2024)1675332
1-1512296-G-A Inborn genetic diseases Uncertain significance (Jan 22, 2024)3130688
1-1512305-G-A Inborn genetic diseases Uncertain significance (Jul 05, 2023)2609736
1-1512307-T-A Likely benign (Apr 01, 2023)2638020
1-1512313-C-T Benign (Dec 14, 2017)709201
1-1512320-C-T Uncertain significance (Jan 21, 2022)2439306
1-1512338-C-T Uncertain significance (May 06, 2022)1723099
1-1512374-G-C Uncertain significance (Dec 16, 2022)2505867
1-1512376-G-C not specified Benign (Jan 24, 2024)2688185
1-1512393-C-T Uncertain significance (Sep 22, 2022)2446095
1-1512399-A-G Harel-Yoon syndrome Uncertain significance (Oct 19, 2021)2442051
1-1512412-C-G Inborn genetic diseases Uncertain significance (Jan 02, 2024)3130682
1-1512418-C-G Harel-Yoon syndrome Uncertain significance (-)992485
1-1512423-C-T Harel-Yoon syndrome Uncertain significance (Aug 25, 2022)1702951
1-1512426-C-T Harel-Yoon syndrome • not specified • Pontocerebellar hypoplasia, hypotonia, and respiratory insufficiency syndrome, neonatal lethal Conflicting classifications of pathogenicity (Apr 04, 2024)225697
1-1512436-G-A Likely benign (Dec 27, 2017)770482
1-1512441-CCGCCAAGGCGGCG-C Uncertain significance (Dec 31, 2019)503862
1-1512447-A-T Inborn genetic diseases Uncertain significance (Jan 19, 2024)3130685
1-1512453-C-T Inborn genetic diseases Uncertain significance (Dec 13, 2022)1304465
1-1512459-A-C Inborn genetic diseases Uncertain significance (Dec 17, 2021)2213780
1-1512464-G-C Inborn genetic diseases Uncertain significance (Aug 09, 2021)2388447
1-1516000-T-C Harel-Yoon syndrome • Pontocerebellar hypoplasia, hypotonia, and respiratory insufficiency syndrome, neonatal lethal • not specified Benign (Jan 24, 2024)1185402

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
ATAD3Aprotein_codingprotein_codingENST00000378755 1622537
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
4.09e-90.9871257010411257420.000163
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense0.01264014020.9980.00002934053
Missense in Polyphen77101.610.757761122
Synonymous-0.9931881711.100.00001261285
Loss of Function2.351933.70.5640.00000194368

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0005950.000589
Ashkenazi Jewish0.00009930.0000992
East Asian0.0001630.000163
Finnish0.00004670.0000462
European (Non-Finnish)0.0001450.000141
Middle Eastern0.0001630.000163
South Asian0.0001310.000131
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Essential for mitochondrial network organization, mitochondrial metabolism and cell growth at organism and cellular level. May play an important role in mitochondrial protein synthesis. May also participate in mitochondrial DNA replication. May bind to mitochondrial DNA D-loops and contribute to nucleoid stability. Required for enhanced channeling of cholesterol for hormone-dependent steroidogenesis. {ECO:0000269|PubMed:17210950, ECO:0000269|PubMed:20154147, ECO:0000269|PubMed:22453275}.;
Disease
DISEASE: Harel-Yoon syndrome (HAYOS) [MIM:617183]: A syndrome characterized by global developmental delay, hypotonia, intellectual disability, and axonal neuropathy. Some patients have optic atrophy and hypertrophic cardiomyopathy. HAYOS inheritance can be autosomal dominant or autosomal recessive. {ECO:0000269|PubMed:27640307}. Note=The disease is caused by mutations affecting the gene represented in this entry.;

Recessive Scores

pRec
0.103

Intolerance Scores

loftool
0.0950
rvis_EVS
0.12
rvis_percentile_EVS
62.21

Haploinsufficiency Scores

pHI
0.301
hipred
N
hipred_score
0.407
ghis
0.518

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.735

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Atad3a
Phenotype
muscle phenotype; homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; skeleton phenotype; embryo phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);

Gene ontology

Biological process
regulation of cell growth;mitochondrion organization;negative regulation of apoptotic process
Cellular component
mitochondrion;mitochondrial inner membrane;integral component of membrane;mitochondrial nucleoid
Molecular function
ATP binding;zinc ion binding